STATO IMMUNOLOGICO IN PAZIENTI CON NEOPLASIE SOLIDE = ETAT IMMUNOLOGIQUE CHEZ DES MALADES ATTEINTS DE NEOPLASIES SOLIDESCITTERIO F; LUCIANI G; POZZETTO U et al.1980; MINERVA CHIR.; ITA; DA. 1980; VOL. 35; NO 10; PP. 717-722; BIBL. 26 REF.Article

Cardiac risk stratification of patients undergoing vascular surgeryROSSI, E; CITTERIO, F.Comprehensive therapy. 1999, Vol 25, Num 11-12, pp 461-466, issn 0098-8243Article

The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activatorsCITTERIO, F; KAHAN, B. D.Transplantation. 1989, Vol 47, Num 2, pp 334-338, issn 0041-1337, 5 p.Conference Paper

Meeting the Early and Late Challenges of Renal Transplantation - Designing de novo Strategies for Improved OutcomesDAL CANTON, A; CITTERIO, F.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, 64 p., SUPConference Proceedings

Evolution of the therapeutic drug monitoring of cyclosporineCITTERIO, F.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 420-425, issn 0041-1345, 6 p., SUPArticle

MTOR-What Does It Do?HALL, M. N.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S5-S8, SUPConference Paper

Neclear effects of cyclosporineCITTERIO, F; CHIOCCA, A. E; KAHAN, B. D et al.Transplantation proceedings. 1990, Vol 22, Num 4, pp 1742-1743, issn 0041-1345, 2 p.Conference Paper

Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot StudyCALIA, R; LAI, C; ACETO, P et al.Transplantation proceedings. 2011, Vol 43, Num 4, pp 1006-1009, issn 0041-1345, 4 p.Conference Paper

Significant Improvement in Patient Survival After Renal Transplantation in the Last DecadeFAVI, E; SALERNO, M. P; ROMAGNOLI, J et al.Transplantation proceedings. 2011, Vol 43, Num 1, pp 285-287, issn 0041-1345, 3 p.Conference Paper

Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label TrialWLODARCZYK, Z; SQUIFFLET, J.-P; PIETRUCK, F et al.American journal of transplantation (Print). 2009, Vol 9, Num 11, pp 2505-2513, issn 1600-6135, 9 p.Article

Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney TransplantationFAVI, E; SPAGNOLETTI, G; VALENTINI, A. L et al.Transplantation proceedings. 2009, Vol 41, Num 4, pp 1218-1220, issn 0041-1345, 3 p.Conference Paper

Higher incidence of acute rejection in renal transplant recipients with low everolimus exposureROMAGNOLI, J; CITTERIO, F; FAVI, E et al.Transplantation proceedings. 2007, Vol 39, Num 6, pp 1823-1826, issn 0041-1345, 4 p.Conference Paper

Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safeCITTERIO, F; DI PINTO, A; BORZI, M. T et al.Transplantation proceedings. 2001, Vol 33, Num 3, pp 2134-2135, issn 0041-1345Conference Paper

Human humoral immune reactions against pig antigens : a method to clear preexisting preformed natural antibodiesPOZZETTO, U; CITTERIO, F; MAGGIANO, N et al.Transplantation proceedings. 1993, Vol 25, Num 1, issn 0041-1345, p. 450, 1Conference Paper

Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation : Reviewing Outcomes With De Novo Use of Sirolimus in Combination With CyclosporineKAHAN, B. D.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S17-S20, SUPConference Paper

Modern Approaches to Combining Sirolimus With Calcineurin InhibitorsSTEVENS, R. B.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S21-S24, SUPConference Paper

Reducing the Risk of Viral Infection in Renal TransplantationTIBBLES, L. A.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S48-S51, SUPConference Paper

Steroid Elimination-Who, When, How?MATAS, A. J.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S52-S56, SUPConference Paper

The Impact of mTOR Inhibitors on the Development of MalignancyGEISSLER, E. K.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S32-S35, SUPConference Paper

IMBALANCES IN PERIPHERAL BLOOD T-CELL SUBPOPULATIONS IN RENAL TRANSPLANT PATIENTSLUCIANI G; MAGGIANO N; CITTERIO F et al.1981; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1981; VOL. 46; NO 3; PP. 615-620; BIBL. 13 REF.Article

Biomarkers-A Potential Route for Improved Diagnosis and Management of Ongoing Renal DamageOBERBAUER, R.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S44-S47, SUPConference Paper

Minimizing the Risk of Posttransplant MalignancyCAMPISTOL, J. M.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S40-S43, SUPConference Paper

T-Regulatory Cells-What Relationship With Immunosuppressive Agents?WEKERLE, T.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S13-S16, SUPConference Paper

Evolution of Causes of Mortality in Renal Transplantation in the Last 10 YearsSALERNO, M. P; ZICHICHI, E; ROSSI, E et al.Transplantation proceedings. 2010, Vol 42, Num 4, pp 1077-1079, issn 0041-1345, 3 p.Conference Paper

MTOR-Understanding the Clinical EffectsCONTRERAS, A. G; DORMOND, O; EDELBAUER, M et al.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S9-S12, SUPConference Paper